Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot # MHA21825, Exp Date: December 31, 2027
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Alvogen, Inc
- Reason for Recall:
- Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- ongoing
Product Information
Full Description:
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Product Codes/Lot Numbers:
Lot # MHA21825, Exp Date: December 31, 2027
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0259-2026
Related Recalls
Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
Sub-Potent Drug: Out of specification for assay at the 24 month interval.
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)